Russell Investments Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.1K | Buy |
2,315
+501
| +28% | +$10.2K | ﹤0.01% | 2996 |
|
|
2025
Q1 | $32.9K | Buy |
1,814
+9
| +0.5% | +$163 | ﹤0.01% | 3001 |
|
|
2024
Q4 | $45.6K | Buy |
1,805
+37
| +2% | +$935 | ﹤0.01% | 2846 |
|
|
2024
Q3 | $60.1K | Sell |
1,768
-2,280
| -56% | -$77.5K | ﹤0.01% | 2757 |
|
|
2024
Q2 | $150K | Buy |
4,048
+4,019
| +13,859% | +$149K | ﹤0.01% | 2545 |
|
|
2024
Q1 | $1.22K | Buy |
+29
| New | +$1.22K | ﹤0.01% | 3119 |
|
|
2018
Q3 | – | Sell |
-753
| Closed | -$6K | – | 2954 |
|
|
2018
Q2 | $6K | Sell |
753
-1,739
| -70% | -$13.9K | ﹤0.01% | 2887 |
|
|
2018
Q1 | $87K | Sell |
2,492
-2,595
| -51% | -$90.6K | ﹤0.01% | 2768 |
|
|
2017
Q4 | $224K | Sell |
5,087
-18,414
| -78% | -$811K | ﹤0.01% | 2644 |
|
|
2017
Q3 | $1.01M | Buy |
23,501
+20,709
| +742% | +$888K | ﹤0.01% | 2144 |
|
|
2017
Q2 | $103K | Sell |
2,792
-1,430
| -34% | -$52.8K | ﹤0.01% | 2800 |
|
|
2017
Q1 | $229K | Sell |
4,222
-1,855
| -31% | -$101K | ﹤0.01% | 2668 |
|
|
2016
Q4 | $325K | Buy |
+6,077
| New | +$325K | ﹤0.01% | 2593 |
|